Vioxx is approved by the FDA.
Study finds Vioxx patients had double the rate of serious cardiovascular problems compared to those taking naproxen.
FDA advisory panel recommends warning label noting possible link to heart attacks and strokes.
The FDA warns Merck for misleading claims about the safety of the drug.
FDA requests that Merck add a warning on the label about cardiovascular problems.
FDA announces results of a study that found Vioxx users were more likely to suffer a heart attack or sudden cardiac
death than those taking Celebrex.
Merck & Co. withdraws Vioxx.
U.S. District Court for the Eastern District of Louisiana begins pretrial proceedings for those people pursuing
their Vioxx lawsuit in federal court.
Texas jury returns a verdict in favor of family of man who died after taking Vioxx. The jury found Merck negligent
in the death of the man.
New Orleans jury returns a $51 million verdict in favor of Gerald Barnett. Mr. Barnett, a retired FBI agent,
was represented by O'Steen & Harrison and Mark Robinson.
Merck announces a global settlement to resolve claims pending in U.S. courts for $4.85 billion.